Inventor · disambiguated record
Steven Emiel Van Der Plas
Also filed as: VAN DER PLAS STEVEN EMIEL
23 granted patents·3 pending applications·62 citations·filing 2014–2022
93Inventor score
Top patents by PatentIndex Score
26 records- 0194US10138227B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2017·Granted Nov 27, 2018·31 cites·29 claims
- 0286US10259810B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2017·Granted Apr 16, 2019·5 cites·8 claims
- 0384US9890158B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2016·Granted Feb 13, 2018·5 cites·50 claims
- 0482US11564923B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2018·Granted Jan 31, 2023·2 cites·19 claims
- 0582US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 0682US9895347B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2016·Granted Feb 20, 2018·3 cites·6 claims
- 0781US9351955B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2015·Granted May 31, 2016·3 cites·14 claims
- 0880US9133210B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2014·Granted Sep 15, 2015·4 cites·14 claims
- 0979US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 1078US10604515B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2018·Granted Mar 31, 2020·1 cites·2 claims
- 1176US10647717B2N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2019·Granted May 12, 2020·1 cites·3 claims
- 1274US10568867B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2018·Granted Feb 25, 2020·1 cites·13 claims
- 1373US12472181B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2022·Granted Nov 18, 2025·0 cites·3 claims
- 1473US9796711B2Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of useABBVIE S ÀR L·Filed 2016·Granted Oct 24, 2017·2 cites·42 claims
- 1572US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 1671US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 1771US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 1871US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 1969US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 2069US9382254B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2014·Granted Jul 5, 2016·2 cites·21 claims
- 2159US2019202823A1N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USEABBVIE SARL·Filed 2019·Application pending·0 cites
- 2255US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 2340US9867806B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2016·Granted Jan 16, 2018·0 cites·18 claims
- 2437US10508111B26-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitorsGALAPAGOS NV·Filed 2016·Granted Dec 17, 2019·0 cites·15 claims
- 2535US10130622B2Compounds for treatment of cystic fibrosisABBVIE SARL·Filed 2016·Granted Nov 20, 2018·0 cites·33 claims
- 2628US10047051B2Substituted pyridines and method of useABBVIE S A ACUTE OVER R L·Filed 2016·Granted Aug 14, 2018·0 cites·47 claims
Join the waitlist — get patent alerts
Get an alert when Steven Emiel Van Der Plas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →